Workflow
IDEX(IEX)
icon
Search documents
IDEX(IEX.US)关键人事落地!法巴银行强调新CFO资本运作背景 投资者担忧有望缓解
Zhi Tong Cai Jing· 2025-12-08 07:09
布斯卡利亚上周五在致客户的报告中表示,吉伦在投资组合管理、并购和资本配置方面的经验与IDEX 当前的重点高度契合,尤其是在资本配置问题仍备受关注的情况下。 在加入AAR之前,吉伦曾担任建筑材料制造商USG公司的副总裁兼财务主管。职业生涯早期,他曾是 高盛全球工业投资银行部门的副总裁,负责并购、企业分拆、股东维权和资本回报计划等工作。 在研究报告中,布斯卡利亚表示,此次聘用的时机意义重大。根据法国巴黎银行的分析,在吉伦任职 AAR期间,每股收益以约9%的复合年增长率增长,调整后EBITDA利润率从8%扩大至约12%。 法国巴黎银行分析师安德鲁.布斯卡利亚在一份报告中表示,IDEX(IEX.US)任命肖恩.吉伦为高级副总裁 兼首席财务官,消除了投资者的一大隐忧,因为这家工业技术公司正在填补今年早些时候空缺的职位。 吉伦还带领AAR度过了飞机售后市场业务的动荡时期,其中包括新冠疫情引发的经济衰退以及持续的 供应链中断。他在多项收购中发挥了主导作用,扩大了公司的业务范围,包括以7800万美元收购 HAECO的零部件部门、以1.46亿美元收购ADI美国分销商以及以1.2亿美元收购Trax。 IDEX表示,吉伦将于明年1 ...
IDEX Corp names new CFO (NYSE:IEX)
Seeking Alpha· 2025-12-04 21:52
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...
IDEX Corporation Appoints Sean Gillen as SVP, Chief Financial Officer
Businesswire· 2025-12-04 21:47
Dec 4, 2025 4:47 PM Eastern Standard Time IDEX Corporation Appoints Sean Gillen as SVP, Chief Financial Officer Share NORTHBROOK, Ill.--(BUSINESS WIRE)--IDEX Corporation (NYSE:IEX) today announced the appointment of Sean M. Gillen as Senior Vice President and Chief Financial Officer of the Company, effective January 5, 2026. Akhil Mahendra, who has served as the Company's interim Chief Financial Officer since May 2025, will return to his role as Vice President, Corporate Development. Mr. Gillen brings exten ...
What Are Wall Street Analysts' Target Price for IDEX Corporation Stock?
Yahoo Finance· 2025-11-24 08:36
Core Insights - IDEX Corporation is valued at a market capitalization of $12.8 billion and operates in diversified industrial technology, focusing on fluid and metering technologies, health and science technologies, and fire, safety, and rescue equipment [1] Stock Performance - IDEX has experienced significant challenges in the stock market, with a decline of 25% over the past year and an 18.5% drop year-to-date, underperforming the S&P 500 Index, which gained 11% and 12.3% during the same periods [2] - The stock has also lagged behind the Industrial Select Sector SPDR Fund's 6.4% rally over the past 52 weeks and 13.6% return this year [3] Earnings Report - On October 29, IDEX shares increased by 3.9% following the release of third-quarter earnings, which showed net sales rising by 10% to approximately $879 million, with 5% organic growth and record quarterly orders [4] - The adjusted EBITDA margin expanded to roughly 27%, contributing to a 7% year-over-year increase in adjusted EPS to $2.03, while record orders of $880 million increased by 13% on a reported basis and 7% organically [4] - Management reaffirmed its full-year outlook and continued capital returns through steady share repurchases, which bolstered investor confidence [4] Analyst Expectations - For fiscal year 2025, analysts expect IDEX's EPS to remain flat at $7.89 on a diluted basis, with a solid history of surpassing consensus estimates in the trailing four quarters [5] - Among 12 Wall Street analysts covering IDEX, the consensus rating is a "Moderate Buy," consisting of six "Strong Buy" ratings, one "Moderate Buy," and five "Hold" ratings [5] Price Target Adjustments - On October 30, 2025, RBC Capital's Deane Dray maintained an "Outperform" rating on IDEX but reduced the price target from $200 to $195, indicating tempered expectations despite ongoing confidence in the stock [6]
IDEX Corporation Declares Regular Quarterly Cash Dividend
Businesswire· 2025-11-13 17:42
Core Points - IDEX Corporation announced a regular quarterly cash dividend of $0.71 per common share, to be paid on January 30, 2026, to shareholders of record as of January 16, 2026, marking the company's 125 consecutive quarterly cash dividend payments [1][4][6] Company Overview - IDEX Corporation is a global engineered products company with three primary business segments: Health & Science Technologies, Fluid & Metering Technologies, and Fire & Safety/Diversified Products [2][3] - The company employs approximately 8,800 people and reported revenues of $3.3 billion and net income of $505 million for the year 2024 [4][6] - Founded in 1988, IDEX operates more than 50 businesses worldwide and has manufacturing operations in over 20 countries [2][3]
IDEX Stock: Underperformance Has Been Value Driven (NYSE:IEX)
Seeking Alpha· 2025-11-10 03:53
Group 1 - The article emphasizes the focus on cash flow and the potential for value and growth in the oil and natural gas sector [1] - Crude Value Insights provides a service that includes a 50+ stock model account and in-depth cash flow analyses of exploration and production (E&P) firms [1] - Subscribers have access to live chat discussions about the sector, enhancing community engagement and information sharing [1] Group 2 - A two-week free trial is offered to new subscribers, promoting engagement with the oil and gas investment service [2]
IDEX Corporation's Underperformance Has Been Value Driven
Seeking Alpha· 2025-11-10 03:53
Core Insights - Crude Value Insights provides an investment service and community focused on the oil and natural gas sector, emphasizing cash flow and the companies that generate it, which leads to value and growth prospects with real potential [1] Company Offerings - Subscribers gain access to a model account with over 50 stocks, in-depth cash flow analyses of exploration and production (E&P) firms, and live chat discussions about the sector [1] Promotional Offer - A two-week free trial is available for new subscribers, allowing them to explore the services related to oil and gas investments [2]
Idex Corporation (NYSE:IEX) Earnings Report Overview
Financial Modeling Prep· 2025-10-29 22:00
Core Insights - IEX reported earnings per share (EPS) of $1.69, which was below the estimated $1.93, but its revenue of $878.7 million exceeded the estimated $861.4 million [1][5] - The revenue of $878.7 million represents a 10.1% increase year-over-year, surpassing the Zacks Consensus Estimate of $858.37 million, resulting in a positive surprise of 2.37% [2] - IEX's financial metrics indicate strong investor confidence, with a price-to-earnings (P/E) ratio of approximately 27.45 and a price-to-sales ratio of about 3.83 [3] Financial Performance - The company achieved a revenue of $878.7 million, showcasing strong financial performance and effective execution across various business units [2][5] - Despite missing EPS estimates, IEX demonstrated resilience with a year-over-year increase in earnings [5] - IEX maintains a strong liquidity position with a current ratio of 2.93, indicating its ability to cover short-term liabilities comfortably [3] Financial Stability - IEX has a very low debt-to-equity ratio of 0.00017, indicating minimal reliance on debt for financing [4] - The company's earnings yield stands at 3.64%, providing insight into the return on investment for shareholders [4] - IEX's enterprise value to sales ratio is around 3.66, and its enterprise value to operating cash flow ratio is approximately 19.44, highlighting its valuation in relation to sales and cash flow from operations [4]
IDEX(IEX) - 2025 Q3 - Quarterly Report
2025-10-29 19:47
Financial Performance - Net sales for Q3 2025 reached $878.7 million, a 10.1% increase from $798.2 million in Q3 2024[15] - Gross profit for Q3 2025 was $390.6 million, up 10.3% from $353.9 million in Q3 2024[15] - Operating income for the nine months ended September 30, 2025, was $515.7 million, slightly up from $511.9 million in the same period of 2024[15] - Net income attributable to IDEX for Q3 2025 was $127.8 million, compared to $119.1 million in Q3 2024, reflecting a 5.8% increase[15] - Basic earnings per share attributable to IDEX for Q3 2025 was $1.70, an increase from $1.57 in Q3 2024[15] - Comprehensive income for Q3 2025 was $124.9 million, down from $210.8 million in Q3 2024[16] - Net income for the nine months ended September 30, 2025, was $354.2 million, a decrease from $381.4 million in the same period of 2024, representing a decline of approximately 7.4%[22] - Adjusted segment EBITDA for Q3 2025 totaled $261.5 million, compared to $235.8 million in Q3 2024, indicating a 10.9% increase[41] - Adjusted segment EBITDA for the nine months ended September 30, 2025, was $758.5 million, compared to $719.7 million for the same period in 2024, reflecting a 5.4% increase[43] - Adjusted diluted EPS attributable to IDEX of $2.03 increased 7%[103] Assets and Liabilities - Total assets as of September 30, 2025, were $6,969.7 million, up from $6,745.3 million at the end of 2024[18] - Cash and cash equivalents decreased to $593.8 million from $620.8 million at the end of 2024[18] - Current liabilities decreased to $564.0 million from $629.7 million at the end of 2024[18] - Retained earnings increased to $4,424.8 million from $4,230.2 million at the end of 2024[18] - The company’s total equity as of September 30, 2025, was $4,010.1 million, a slight decrease from $4,011.4 million at the end of the previous year[20] - Total cash and cash equivalents at the end of the period on September 30, 2025, were $599.7 million, down from $651.3 million at the same time in 2024[22] - Total borrowings as of September 30, 2025, amounted to $1,911.8 million, a decrease from $1,971.3 million at the end of 2024, representing a reduction of 3.0%[62] Cash Flow and Expenditures - Cash flows provided by operating activities for the nine months ended September 30, 2025, totaled $470.9 million, compared to $495.5 million in 2024, indicating a decrease of about 4.9%[22] - Capital expenditures for the nine months ended September 30, 2025, were $43.9 million, slightly lower than $49.6 million in 2024[22] - Free cash flow for the nine months ended September 30, 2025, was $427.0 million, down from $445.9 million in 2024, reflecting lower cash flows from operating activities[131] Segment Performance - The Health & Science Technologies segment generated $380.1 million in sales, up from $309.9 million in the same quarter last year, reflecting a 22.6% growth[41] - Health & Science Technologies segment net sales for the nine months ended September 30, 2025, were $1,084.1 million, up from $922.3 million in 2024, representing a 17.5% increase[46] - Fluid & Metering Technologies segment net sales decreased slightly to $917.5 million in the nine months ended September 30, 2025, from $933.0 million in 2024, a decline of 1.6%[46] - Fire & Safety/Diversified Products segment net sales for the nine months ended September 30, 2025, were $556.8 million, compared to $550.6 million in 2024, showing a modest increase of 1.4%[46] Acquisitions and Investments - The acquisition of Micro-LAM, Inc. was completed for a total consideration of $81.9 million, including $36.9 million in goodwill and $44.8 million in intangible assets[31] - The acquisition of Mott Corporation was finalized for $982.0 million, with $488.6 million in goodwill and $412.8 million in intangible assets recognized[35] - Acquisition-related costs for Q3 2025 amounted to $1.9 million, compared to $5.5 million in Q3 2024[36] - The company reported a gain of $4.0 million from the sale of Alfa Valvole, Srl, completed on June 3, 2024[39] Shareholder Returns - The company declared cash dividends of $159.4 million during the nine months ended September 30, 2025, compared to $153.0 million in 2024, reflecting an increase of approximately 4.9%[22] - The company authorized an additional $635.0 million for share repurchases on September 17, 2025, in addition to the previous $500.0 million authorization from March 17, 2020[78] - During the nine months ended September 30, 2025, the company repurchased 1.0 million shares at a cost of $176.6 million, with no repurchases made in the same period of 2024[78] Tax and Compliance - The effective tax rate for the three months ended September 30, 2025, was 25.1%, compared to 22.9% for the same period in 2024[95] - The company expects incremental income tax disclosures following the adoption of ASU 2023-09 in its 2025 Annual Report[26] - The company is evaluating the impact of ASU 2024-03, which will require disaggregated expense disclosures starting in 2027[27] Miscellaneous - The company expects to incur approximately $20 million in restructuring costs primarily related to severance as part of its 2025 initiative[71] - The company has assessed its intangible assets and goodwill for impairment, concluding that all reporting units had fair values exceeding their carrying values as of the last assessment date[59] - There were no material changes in market risks or risk factors compared to the previous annual report[148][155]
IDEX narrows full-year EPS guidance to $7.86-$7.91 as HST momentum offsets FSDP headwinds (NYSE:IEX)
Seeking Alpha· 2025-10-29 18:57
Core Insights - The article discusses the importance of enabling Javascript and cookies in browsers to ensure proper functionality and access to content [1] Group 1 - The article highlights that users may face access issues if they have an ad-blocker enabled [1] - It suggests disabling ad-blockers and refreshing the page to proceed [1]